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Background. Excessive interdialytic weight gain (IDWG) is
usually related to an overload of sodium and water, and is the
most important factor for arterial hypertension in dialysis. On
the other hand, food intake also contributes to IDWG, and is the
basic factor for nutrition. The objective of this study is to assess
the long-term prognostic effect of IDWG and its relationship
with the nutritional status and blood pressure in patients in
hemodialysis (HD).
Methods. We describe the results of a 5-year prospective ob-
servation study in which 134 HD patients were included (70
males and 64 females), with ages between 18 and 81. Initially,
the average data were collected during 4 weeks, including total
IDWG and percentages according to dry weight (IDWG%), nu-
tritional parameters, and blood pressure. Patients were divided
into 3 cohorts according to IDWG% (<2.9, 2.9–3.9, and >3.9%,
respectively). Student t test, ANOVA, linear regression analy-
sis, and Kaplan-Meier survival curves compared with log-rank
test were used as statistical tools.
Results. The mean IDWG% for the whole studied population
was 3.5 ± 1.1% (1.5–8.0%). It was not related to gender, but had
an inverse correlation with age (P < 0.000) and serum bicarbon-
ate level (P = 0.009). It was directly correlated with predialysis
systolic and diastolic blood pressure, nPCR, urea and creati-
nine levels (P < 0.01 for all of them), and the body mass index
(P < 0.000). Serum levels of albumin (44.7 ± 4.0 g/dL) and pre-
albumin (31.9 ± 7.4 mg/dL) had a direct correlation with total
IDWG (P < 0.01). We found no significant relationship between
or IDWG% and ferritin and transferrin levels. Five-year actuar-
ial survival was 0.38, 0.52, and 0.63, respectively, in the 3 cohorts
for IDWG% (P < 0.01).
Conclusion. Our results show that a greater IDWG is directly
associated with a better nutritional status, although it is also as-
sociated with higher predialysis blood pressure. The greater the
IDWG%, the better the long-term prognosis of the patients.
The beneficial effects of IDWG on the nutritional status and
prognosis are greater than the negative aspects that depend on
its effects on blood pressure. One must distinguish clearly be-
tween some isolated instances of not complying with a diet from
those situations where a higher IDWG is merely a reflection of
a good nutritional status, and one must be careful so that dietary
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recommendations will not have a negative influence on nutri-
tional aspects. One must watch and correct the trend towards
higher acidosis in patients with a greater IDWG.
Interdialytic weight gain (IDWG) is mainly the result
of salt and water intake between two dialysis sessions.
Theoretically, the consequences of this variable have a
double meaning. On the one hand, the water and saline
intake can frequently be done together with caloric and
protein foods, which means it would be associated with
a better nutritional status [1–4]. But, on the other hand,
water and salt intake can give rise to a volume overload,
which can be the key for the developing of high blood
pressure [5–11] and left ventricle hypertrophy, both of
which can increase the cardiovascular risk [12, 13].
The objective of this study was to assess the long-term
prognostic effect of IDWG and its relationship with the
nutritional status and blood pressure of the patients on
hemodialysis (HD).
METHODS
We prospectively studied the outcome of 134 patients,
70 men and 64 women, with an average age of 60.6 ± 14.5
years (18–81 years), and with an average time on dialysis
of 43.8 ± 23.0 months. All of them received conventional
hemodialysis 3 times a week, with a mean duration of
3.7 ± 0.4 hours. Sixty-eight percent was dialyzed with
high flux membranes. The spKt/V and normalized protein
catabolic rate (nPCR) were calculated with the kinetic
urea model [14].
The etiology of chronic renal failure included 18.7%
glomerulonephritis, 26.1% chronic interstitial nephropa-
thy, 9.0% vascular nephropathy, 11.9% diabetes mellitus,
10.4% polycystic disease, other in 5.2%, and unknown in
18.7%.
Patients were initially evaluated during 4 weeks, de-
termining the IDWG and blood pressure as an average
of the 12 hemodialysis sessions given during that period.
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Table 1. Clinical and analytical characteristics of the 134 patients at
the start of the study
Mean SD
Age years 60.6 14.5
Time on HD months 43.8 23.0
Dry weight kg 65.0 12.7
Body mass index kg/m2 23.8 3.4
Systolic blood pressure mm Hg 136.4 14.2
Diastolic blood pressure mm Hg 72.9 8.8
Mean arterial pressure mm Hg 94.1 9.7
Antihypertensive drugs number 0.78 0.86
Interdialytic weight gain kg 2.2 0.8
Interdialytic weight gain/dry weight % 3.5 1.1
Albumin g/L 44.7 4.0
Prealbumin mg/dL 39.1 7.4
nPCR g/kg/min 1.06 0.22
spKt/V 1.30 0.13
Bicarbonate mEq/L 24.0 2.7
Calcium mg/dL 9.9 0.7
Phosphate mg/dL 5.7 1.2
Urea mg/dL 155.7 33.2
Creatinine mg/dL 9.5 2.4
Transferrin mg/dL 215.4 39.6
Ferritin ng/mL 459.5 297.9
Results are expressed as mean ± standard deviation.
Mean blood pressure (MBP) was calculated as
MBP = [systolic blood pressure
+ (2 × diastolic blood pressure)]/3.
Patients were classified according to tertiles of MBP:
group A included 44 patients with MBP <90 mm Hg;
group B included 45 patients with MBP 90 to 94 mm Hg,
and group C included 45 patients with MBP >94 mm Hg.
IDWG is expressed as the difference between the pre-
dialysis weight and the weight at the end of the previous
dialysis session, and IDWG% is obtained using the per-
centage relationship between the average IDWG and the
patient’s dry weight. Patients were classified into 3 co-
horts according to the IDWG%: <3% (Group I), 3% to
3.9% (Group II), and >3.9% (Group III). The amount of
antihypertensive drugs the patients were taking daily was
recorded, and we calculated the body mass index (BMI).
Table 1 shows the clinical characteristics and the anal-
ysis of the patients at the beginning of the study. The
follow-up of the patients was done over 5 years.
Results are expressed as mean ± standard deviation.
The comparison between the mean values was done with
a Student t test and analysis of variance (ANOVA). The
association between continuous variables was done with
a univariate regression analysis. Pearson correlation co-
efficient was calculated to study these variables. Actuarial
survival was calculated with the Kaplan-Meier method,
and the comparison between groups with the log-rank
test. Statistically significant data were considered to be
those that had a P < 0.05. We used the SPSS 11.5 statistical
software package (Chicago, IL, USA) for the statistical
calculations.
RESULTS
Table 2 shows the clinical results and the analysis of
the 3 groups of patients according to IDWG%. We found
a significant direct correlation between IDWG and dry
weight (r = 0.532, P < 0.01). IDWG is significantly higher
in men than in women (2.4 ± 0.8 vs. 2.0 ± 0.6, P < 0.005),
but this difference disappears when they are adjusted to
dry weight. We found no significant differences in the
IDWG according with etiology. In the linear regression
analysis there was no association between IDWG and
time on dialysis.
There was a significant inverse correlation between
IDWG and IDWG% with age (r = −0.428 and −0.384,
respectively, P < 0.001), serum bicarbonate (r = −0.225
and −0.316, respectively, P < 0.001), and a correlation be-
tween IDWG with spKt/V (r = −0.344, P < 0.001). There
was a significant direct correlation between IDWG% and
serum albumin levels (r = 0.214, P = 0.013), prealbumin
(r = 0.253, P = 0.004), phosphate (r = 0.228, P = 0.008),
urea (r = 0.381, P < 0.001), and creatinine (r = 0.465, P <
0.001), and also with the nPCR (r = 0.287, P < 0.001) and
the body mass index (r = 0.346, P < 0.001). We found
no significant correlation between IDWG% and either
transferrin or ferritin serum levels.
On the other hand, IDWG% was associated with pre-
dialysis blood pressure, both systolic (r =0.314, P <0.001)
and diastolic (r = 0.309, P < 0.001). Figure 1 shows the
relationship between IDWG% and the predialysis MBP.
Besides, there is a direct correlation between IDWG%
and the daily number of antihypertensive drugs that the
patients were taking (r = 0.250, P < 0.005)
After 5 years of follow-up, 59 patients (44.0%) have
died, 21 patients (15.7%) have been transplanted, 4 pa-
tients (3%) have moved to another hospital, and 50
(37.3%) are still actively on hemodialysis. Figure 2 shows
the influence of IDWG% on patient survival at 5 years,
so that those that have the greatest IDWG% have the
best survival. Survival for all 3 groups at 5 years was 0.38,
0.52, and 0.63, respectively (log-rank P < 0.01).
Figure 3 shows the survival of patients at 5 years in
the groups set up according to the tertiles of mean blood
pressure. No significant differences were found.
DISCUSSION
Interdialytic weight gain is considered as a measure-
ment of HD compliance. This measurement varies a great
deal between patients.
While some authors find a favorable association be-
tween IDWG and the nutritional status [1–4], others re-
late it to the blood pressure of patients on HD, which
would be unfavorable [5, 6, 8, 9, 10] The clinical impli-
cations and the medium- and long-term prognostic value
are therefore unclear.
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Table 2. Clinical and analytic characteristics of the 134 patients according to the three groups of interdialytic weight gain/dry weight
(IDWG/DW, %)
Group I Group II Group III P value
IDWG/DW (%) <3 3.1–3.9 >3.9
N 44 45 45
Age years 68.0 ± 8.9 62.9 ± 11.5 51.1 ± 16.6 0.000
Systolic blood pressure mm Hg 132.3 ± 13.5 136.0 ± 13.7 140.9 ± 14.2 0.017
Diastolic blood pressure mm Hg 69.7 ± 9.3 72.0 ± 8.0 76.9 ± 7.6 0.000
Mean arterial pressure mm Hg 90.6 ± 10.1 93.3 ± 8.9 98.2 ± 8.5 0.001
Antihypertensive drugs number 0.6 ± 0.8 0.6 ± 0.7 1.1 ± 0.9 0.001
Albumin g/L 43.8 ± 4.2 44.5 ± 3.6 45.8 ± 4.0 0.05
Prealbumin mg/dL 29.8 ± 8.0 32.6 ± 7.2 33.4 ± 6.6 0.06
nPCR g/kg/min 1.00 ± 0.17 1.04 ± 0.21 1.13 ± 0.25 0.01
spKt/V 1.34 ± 0.17 1.24 ± 0.09 1.31 ± 0.11 0.05
Bicarbonate mEq/L 25.0 ± 2.9 23.7 ± 2.5 23.4 ± 2.6 0.015
Calcium mg/dL 9.7 ± 0.85 9.9 ± 0.67 10.1 ± 0.57 0.04
Phosphate mg/dL 5.2 ± 1.0 6.1 ± 1.1 5.8 ± 1.5 0.009
Urea mg/dL 141.9 ± 35.4 162.3 ± 28.5 162.7 ± 31.9 0.003
Creatinine mg/dL 8.4 ± 2.1 9.5 ± .1 10.7 ± 2.4 0.000
Results are expressed as mean ± standard deviation. Statistical comparison was performed with ANOVA.
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Fig. 1. Relationship between mean blood pressure and interdialytic
weight gain/dry weight (%) in the 134 patients of the study.
Salt and water intake during the interdialysis period
is the most important cause for IDWG. Usually, sodium
intake with food is the most important thirst-stimulating
factor. Nevertheless, other less important factors have
also been involved in this mechanism, such as sodium
concentration in the dialysis fluid, saline solution infu-
sions during the HD session, especially during its final
minutes, residual renal function, or hyperglycemia in di-
abetic patients [15–19].
IDWG is usually quite constant for each patient, and
is influenced by nutritional habits, environmental factors,
and the level of self-care. Nevertheless, it increases in the
longer interdialysis periods during weekends, and under-
goes some variations between different periods. For this
reason, in this study, we recorded the arithmetic mean of
IDWG during 12 sessions of HD, which correspond to 4
consecutive weeks.
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Fig. 2. Survival of the different groups of patients according to interdi-
alytic weight gain/dry weight (%). Group I: patients with IDWG <3%;
group II: patients with IDWG 3.1% to 3.9%; and group III: patients
with IDWG >3.9%
There are some anthropometric characteristics of pa-
tients that can modify the variability of IDWG. Our data
clearly show that age is a variable that is inversely re-
lated to IDWG. Younger patients usually have a larger
appetite, which is accompanied by a larger sodium and
water intake. These results confirm recent previous stud-
ies [9, 20]. Although this is something that is seen in the
general population, it could also be the result of a lower
comorbidity usually associated with a younger age.
IDWG is greater in men than in women, whereas, after
an adjustment made for dry weight, there is no significant
difference any more between both genders. Similar data
have been described by other authors [20].
BMI is considered to be an important marker for the
nutritional status and, in some cases, behaves as if it were
related to the survival of patients on HD [4, 21, 22].
In the patients we studied there was a strong positive
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Fig. 3. Survival of the different groups of patients according to tertiles
of mean blood pressure. Group A: MBP <90 mm Hg; group B: MBP
90 to 94 mm Hg; and group C: MBP >94 mm Hg.
correlation between IDWG% and BMI, although it lost
its statistical significance when IDWG was adjusted to
dry weight. Nevertheless, other authors have shown that
patients with an IDWG% of less than 3% have a signif-
icantly lower BMI than those whose IDWG% is >3%
[3]. Bearing in mind that the variations in BMI happen
slowly in each patient, with these data it could be estab-
lished that IDWG has a great influence on the nutritional
status of patients on HD.
High blood pressure is a common complication in pa-
tients on HD, and its management is complicated [23,
24]. Extracellular volume expansion is its most important
cause, and this depends a great deal on IDWG [11, 25]. In
a recent study with 5369 patients, Rahman et al showed
that greater IDWG and noncompliance with dialysis regi-
men are independent associated factors with higher blood
pressure [8]. These authors also showed that higher blood
pressure is associated with left ventricle hypertrophy [8],
which is other associated risk factor [13].
In our study, we found that IDWG was associated with
a rise in systolic and diastolic blood pressure, and with
mean arterial pressure. This association is controversial.
Some authors have not found any relationship between
IDWG and blood pressure [19, 26, 27, 28], while others
with similar results to ours show an association between
IDWG and blood pressure [2, 5, 8, 9, 10, 29]. Neverthe-
less, in the group of patients that we studied, MBP is not
a risk factor for mortality at 5 years. Quite the contrary,
the lowest mean blood pressure may be a factor for poor
prognosis. These data are similar to those described by
other authors in large series of patients on hemodialysis,
where the distribution of the relative risk of death had a
U shape [30, 31], and in which only the patients with se-
vere hypertension were a mortality risk group, whereas
those with predialysis hypotension had a lower survivial.
Rahman et al found that uncontrolled hypertensive pa-
tients had a greater IDWG compared with controlled hy-
pertensives [5].
On the other hand, we found IDWG to have a sig-
nificant correlation with nutritional parameters such as
serum albumin, prealbumin, urea, and creatinine, as also
with nPCR and the body mass index. Serum albumin is
a marker for inflammation and nutrition that plays an
important role as an independent risk factor for mortal-
ity [32]. There are significant differences between the 3
groups of IDWG% that have been established, so that
those with the greater IDWG% maintain better albumin
levels. Similar findings have been described by other au-
thors [1, 2, 3 15]. In our case, we did not record any other
inflammation markers, so it is hard to say if the patients
were less well nourished because they had an inflamma-
tory status initially, or if their nutritional status depended
on other factors.
nPCR measured by the kinetic urea model is an index
of protein intake. Sherman et al showed that in a large
number of patients on HD, IDWG and IDWG% are cor-
related with nPCR, and suggested that, at least in some
patients, IDWG should be interpreted as a nutritional
marker that can be associated to a better prognosis [1].
Our findings confirmed these results and those of other
authors [2, 3]. It is therefore important to stress that pa-
tients with a low IDWG may be at risk for developing
malnutrition.
Besides, patients have a positive correlation between
IDWG and phosphate levels. It is important to notice that,
in our series, we did not analyze the intake of phosphate
binders that the patients were taking, but in any case, one
can suppose that serum phosphate levels can be a marker
for protein intake in patients on HD. Nevertheless, this
finding is not shared by other authors [15].
The patients with the greatest IDWG% had signifi-
cantly lower serum bicarbonate levels than those who
had a lesser IDWG%.
This association has also been described recently by
Agroyannis et al in 8 stable patients on HD [34]. These
findings suggest that the larger nutritional intake, espe-
cially proteins, may give rise to a greater generation of
acid radicals. Thus, patients on HD with a greater IDWG
may require higher concentrations of bicarbonate in or-
der to reach a normal acid-base status, while patients with
a low IDWG may need lower concentrations of bicarbon-
ate to prevent alkalosis at the end of the HD session, and
with it, the risks of vascular calcifications.
Very few authors have evaluated the effect of IDWG
on the mortality of patients on HD, and the published
series only include short-term results, and with differ-
ent outcomes. Sezer et al, in a small group of patients,
showed that the mortality at 2 years is significantly greater
in those patients who have a lower IDWG [3], while in
American series, IDWG has been described to have a
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direct relationship with the mortality rate, albeit only
in diabetic patients. [15]. In the patients included in the
FMC-North America database, it has been proven that,
although IDWG is directly associated with nutritional
parameters such as albumin, creatinine, phosphate, and
potassium, the 1-year mortality in diabetics is also higher
in patients with a greater IDWG%. These findings were
not seen in nondiabetic patients [35]. The USRDS also
shows that large IDWG are associated with shorter sur-
vival [36].
To our knowledge, there are no other published studies
that assess the impact of IDWG on the course of patients
on HD in the long term. In our 5-year follow-up study,
there are statistical differences in patients survival ac-
cording to the IDWG%, so that those with an IDWG%
lesser than 3% are a group with a high mortality risk af-
ter 5 years. The differences found in the prognostic value
between the series of American and European patients
still need a clear explanation.
CONCLUSION
In this study, IDWG had a double association and a
different prognostic meaning. On the one hand, it was
associated with nutritional parameters, whereas on the
other, it was associated with the levels of blood pressure.
Nevertheless, the balance between both forces with a dif-
ferent meaning was slanted favorably towards nutrition,
suggesting that the specific weight of the nutritional sta-
tus of patients on HD is clearly more important that the
negative effect is has on blood pressure. In this sense, it is
important to stress that patients on HD need nutritional
education in order to reduce the consumption of sodium
in the diet [36, 37], avoiding restrictive advice that could
give rise to a possible negative effect on nutrition.
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